Sedative, hypnotic or anxiolytic dependence, uncomplicated
ICD-10 F13.20 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic dependence, uncomplicated.
F13.20 refers to a diagnosis of dependence on sedative, hypnotic, or anxiolytic substances without any accompanying complications. This condition is characterized by a compulsive pattern of use, leading to significant impairment or distress. Patients may exhibit tolerance, requiring increased dosages to achieve the desired effect, and may experience withdrawal symptoms when not using the substance. Common substances in this category include benzodiazepines and barbiturates. The diagnosis is made based on clinical evaluation, including a thorough history of substance use, assessment of withdrawal symptoms, and the impact on daily functioning. Treatment typically involves a combination of behavioral therapies and, in some cases, pharmacotherapy to manage withdrawal symptoms and support recovery. It is crucial for healthcare providers to monitor patients closely for signs of misuse and to provide education on the risks associated with long-term use of these substances.
Detailed history of substance use, treatment plans, and progress notes.
Patients presenting with withdrawal symptoms, seeking detoxification, or in need of long-term management.
Ensure accurate documentation of the severity of dependence and any co-occurring mental health disorders.
Comprehensive psychiatric evaluation, including mental status examination and risk assessment.
Patients with co-occurring anxiety disorders and sedative dependence.
Document any psychiatric comorbidities that may complicate treatment.
Used in conjunction with F13.20 for therapy sessions.
Document the number of sessions and treatment goals.
Ensure alignment with treatment plans in addiction medicine.
Dependence involves a compulsive pattern of use leading to tolerance and withdrawal, while abuse refers to the harmful use of substances without necessarily meeting dependence criteria.
